
MedinCell S.A.
MEDCL | PA
Overview
Corporate Details
- ISIN(s):
- FR0004065605
- LEI:
- 969500R79U6PXCL2FF46
- Country:
- France
- Address:
- 3 RUE DES FRERES LUMIERE, 34830 JACOU
- Website:
- https://www.medincell.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
MedinCell® is a pharmaceutical company at premarketing stage that develops innovative long-acting injectable medicines in many therapeutic areas. Products of our portfolio are based on our BEPO® technology and aim to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier one pharmaceuticals companies and foundations to improve Global Health through new therapeutic options.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-17 17:45 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 405.2 KB | |
2025-06-17 17:45 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 395.7 KB | |
2025-06-10 18:00 |
Inside Information Statement
Inside Information / Other news releases
|
English | 185.6 KB | |
2025-06-10 18:00 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 192.0 KB | |
2025-06-06 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 183.7 KB | |
2025-05-28 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 183.1 KB | |
2025-05-28 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 156.6 KB | |
2025-05-28 17:45 |
Regulatory News Service
Inside Information / Other news releases
|
English | 220.0 KB | |
2025-05-28 17:45 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 218.7 KB | |
2025-05-21 18:36 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 183.5 KB | |
2025-05-07 15:12 |
Earnings Release
Inside Information / Other news releases
|
English | 227.6 KB | |
2025-05-07 15:12 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 217.5 KB | |
2025-04-22 18:11 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 194.3 KB | |
2025-04-22 18:11 |
Regulatory News Service
Inside Information / Other news releases
|
English | 208.5 KB | |
2025-04-15 19:48 |
Transaction in Own Shares
Informations privilégiées / Autres communiqués
|
French | 283.2 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2023-05-02 | N/A | Other | Sell | 60,000 | 600,006.00 EUR |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
|
Ascelia Pharma | Sweden | ACE | |
![]() |
Atrys Health S.A. | Spain | ATRY | |
![]() |
AUKETT SWANKE GROUP PLC | United Kingdom | AUK | |
|
Azorean - Aquatic Technologies S.A. | Portugal | MLAAT | |
|
Bachem Holding AG | Switzerland | BANB | |
![]() |
Bavarian Nordic | Denmark | BAVA | |
|
BB Biotech AG | Switzerland | BION | |
![]() |
BEEKS FINANCIAL CLOUD GROUP PLC | United Kingdom | BKS | |
![]() |
BenevolentAI | United Kingdom | BAI | |
![]() |
BerGenBio | Norway | BGBIO |